JP2020511454A5 - - Google Patents

Download PDF

Info

Publication number
JP2020511454A5
JP2020511454A5 JP2019549411A JP2019549411A JP2020511454A5 JP 2020511454 A5 JP2020511454 A5 JP 2020511454A5 JP 2019549411 A JP2019549411 A JP 2019549411A JP 2019549411 A JP2019549411 A JP 2019549411A JP 2020511454 A5 JP2020511454 A5 JP 2020511454A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
pharmaceutically acceptable
acceptable salt
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019549411A
Other languages
English (en)
Japanese (ja)
Other versions
JP7142022B2 (ja
JP2020511454A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/021481 external-priority patent/WO2018165385A1/en
Publication of JP2020511454A publication Critical patent/JP2020511454A/ja
Publication of JP2020511454A5 publication Critical patent/JP2020511454A5/ja
Application granted granted Critical
Publication of JP7142022B2 publication Critical patent/JP7142022B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019549411A 2017-03-08 2018-03-08 Malt1の阻害剤およびそれらの使用 Active JP7142022B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762468758P 2017-03-08 2017-03-08
US62/468,758 2017-03-08
US201762553336P 2017-09-01 2017-09-01
US62/553,336 2017-09-01
PCT/US2018/021481 WO2018165385A1 (en) 2017-03-08 2018-03-08 Inhibitors of malt1 and uses thereof

Publications (3)

Publication Number Publication Date
JP2020511454A JP2020511454A (ja) 2020-04-16
JP2020511454A5 true JP2020511454A5 (cg-RX-API-DMAC10.html) 2021-04-15
JP7142022B2 JP7142022B2 (ja) 2022-09-26

Family

ID=63448912

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019549411A Active JP7142022B2 (ja) 2017-03-08 2018-03-08 Malt1の阻害剤およびそれらの使用

Country Status (4)

Country Link
US (1) US11248007B2 (cg-RX-API-DMAC10.html)
EP (1) EP3592731A4 (cg-RX-API-DMAC10.html)
JP (1) JP7142022B2 (cg-RX-API-DMAC10.html)
WO (1) WO2018165385A1 (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3736277A1 (en) * 2016-07-29 2020-11-11 Lupin Limited Substituted thiazolo-pyridine compounds as malt1 inhibitors
WO2018020474A1 (en) * 2016-07-29 2018-02-01 Lupin Limited Substituted thiazolo-pyridine compounds as malt1 inhibitors
TWI795381B (zh) 2016-12-21 2023-03-11 比利時商健生藥品公司 作為malt1抑制劑之吡唑衍生物
BR112021009994A2 (pt) * 2018-11-28 2021-08-17 Takeda Pharmaceutical Company Limited composto, e, medicamento
KR102982241B1 (ko) * 2019-03-12 2026-06-25 오르토-클리니칼 다이아그노스틱스, 인코포레이티드 자가항체 검출용 조성물, 키트, 및 방법
US12404260B2 (en) * 2019-04-11 2025-09-02 Janssen Pharmaceutica Nv Pyridine rings containing derivatives as MALT1 inhibitors
TW202115077A (zh) * 2019-07-01 2021-04-16 大陸商上海齊魯銳格醫藥研發有限公司 Malt1抑制劑及其用途
EP4163280A4 (en) * 2020-05-27 2024-06-05 Takeda Pharmaceutical Company Limited METHOD FOR PRODUCING A HETEROCYCLIC COMPOUND
JP2023549835A (ja) * 2020-11-12 2023-11-29 モノプテロス セラピューティクス,インコーポレーテッド がんを治療する材料及び方法
EP4284804A1 (en) 2021-01-26 2023-12-06 Schrödinger, Inc. Tricyclic compounds useful in the treatment of cancer, autoimmune and inflammatory disorders
JP2025501056A (ja) 2021-12-30 2025-01-17 シャンハイ ハンソー バイオメディカル カンパニー リミテッド 三環系誘導体阻害剤、その製造方法と応用
JP2026510946A (ja) * 2023-03-17 2026-04-10 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア レチンアルデヒドデヒドロゲナーゼ1(raldh1)阻害剤および免疫賦活剤の組み合わせならびにそれらの使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5596001A (en) 1993-10-25 1997-01-21 Pfizer Inc. 4-aryl-3-(heteroarylureido)quinoline derivatves
US9090592B2 (en) * 2010-12-30 2015-07-28 AbbVie Deutschland GmbH & Co. KG Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
GB2504550A (en) 2012-08-03 2014-02-05 Nanyang Polytechnic Diarylurea compound PQ401 for inhibiting the growth and/or proliferation of cancer stem cells
EA201590916A1 (ru) 2012-11-09 2016-02-29 Корнэлл Юниверсити Низкомолекулярные ингибиторы malt1
WO2014086478A1 (en) 2012-12-03 2014-06-12 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Inhibitors of malt1 protease
JP6545197B2 (ja) 2014-05-28 2019-07-17 ノバルティス アーゲー 新規なピラゾロピリミジン誘導体およびmalt1阻害剤としてのその使用
WO2018020474A1 (en) 2016-07-29 2018-02-01 Lupin Limited Substituted thiazolo-pyridine compounds as malt1 inhibitors
US10689366B2 (en) 2016-11-01 2020-06-23 Cornell University Compounds for MALT1 degredation

Similar Documents

Publication Publication Date Title
JP2019537599A5 (cg-RX-API-DMAC10.html)
JP6933770B2 (ja) Hivカプシド阻害剤のコリン塩形態
US10774065B2 (en) 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2
AU2018254577B2 (en) Combination therapies with EHMT2 inhibitors
JP2021191798A (ja) Hivカプシド阻害剤の固体形態
AU2015207757B2 (en) N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of SHP2
JP2021008516A (ja) Hivウイルス感染症の予防的または治療的処置に有用な治療用化合物
JP2018522866A5 (cg-RX-API-DMAC10.html)
JP2019527718A5 (cg-RX-API-DMAC10.html)
JP2016531113A5 (cg-RX-API-DMAC10.html)
JP2017511360A5 (cg-RX-API-DMAC10.html)
JP2017537940A5 (cg-RX-API-DMAC10.html)
JP2009536620A5 (cg-RX-API-DMAC10.html)
JP2016533379A5 (cg-RX-API-DMAC10.html)
RU2013108348A (ru) Конденсированные гетероарилы и их применение
JP2017526675A5 (cg-RX-API-DMAC10.html)
RU2017111200A (ru) Циклогексилэтилзамещенные диаза- и триаза-трициклические соединения в качестве антагонистов индоламин-2,3-диоксигеназы для лечения рака
JP2018526413A5 (cg-RX-API-DMAC10.html)
JP2021534108A5 (cg-RX-API-DMAC10.html)
JP2018516238A5 (cg-RX-API-DMAC10.html)
JP2018519245A5 (cg-RX-API-DMAC10.html)
RU2017124136A (ru) Трициклическое спиро-соединение
JP2014508804A5 (cg-RX-API-DMAC10.html)
JP2015511638A5 (cg-RX-API-DMAC10.html)
JP2005535586A5 (cg-RX-API-DMAC10.html)